The site-specific modification of therapeutic proteins produced in Escherichia coli

2010 ◽  
Author(s):  
Kevin D. Isett

2019 ◽  
Vol 38 (5) ◽  
pp. 576-585
Author(s):  
Yao Zhang ◽  
Qunfeng Ma ◽  
Junfeng Wang ◽  
Jianlin Ge ◽  
Jilei Hua ◽  
...  


2020 ◽  
Vol 56 (77) ◽  
pp. 11473-11476
Author(s):  
Si Si Liew ◽  
Chengwu Zhang ◽  
Jie Zhang ◽  
Hongyan Sun ◽  
Lin Li ◽  
...  

Adopting orthogonal dual-labeling strategies, a cell-permeable RNase A prodrug was designed for ROS-responsive targeted cancer therapy.



Biochemistry ◽  
1984 ◽  
Vol 23 (9) ◽  
pp. 2073-2078 ◽  
Author(s):  
Anup K. Hazra ◽  
Sevilla Detera-Wadleigh ◽  
Samuel H. Wilson




Biochemistry ◽  
1995 ◽  
Vol 34 (4) ◽  
pp. 1107-1112 ◽  
Author(s):  
Miklos Sahin-Toth ◽  
Rhonda L. Dunten ◽  
H. Ronald Kaback


ChemBioChem ◽  
2017 ◽  
Vol 18 (19) ◽  
pp. 1923-1927 ◽  
Author(s):  
Philipp R. Spycher ◽  
Christian A. Amann ◽  
Jöri E. Wehrmüller ◽  
David R. Hurwitz ◽  
Olivier Kreis ◽  
...  


Gene Therapy ◽  
2001 ◽  
Vol 8 (12) ◽  
pp. 961-965 ◽  
Author(s):  
KK Goncz ◽  
A Colosimo ◽  
B Dallapiccola ◽  
L Gagné ◽  
K Hong ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document